
What Trump (Allegedly) Said About Epstein
Start Here
00:00
Regulatory scrutiny for compound pharmacies
Mary Kikatos outlines FDA concerns, potential restrictions on GLP-1 compounding, and broader implications for pharmacies.
Play episode from 22:47
Transcript


